PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 233 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,959 | +18.6% | 174,025 | -44.7% | 0.04% | -36.7% |
| Q2 2023 | $12,610 | -1.8% | 314,691 | 0.0% | 0.06% | -9.1% |
| Q1 2023 | $12,843 | +6.8% | 314,691 | +1.0% | 0.07% | 0.0% |
| Q4 2022 | $12,028 | -99.9% | 311,534 | +0.8% | 0.07% | -30.5% |
| Q3 2022 | $16,444,000 | -8.8% | 309,147 | 0.0% | 0.10% | -4.0% |
| Q2 2022 | $18,023,000 | -39.7% | 309,147 | -21.0% | 0.10% | -27.2% |
| Q1 2022 | $29,875,000 | +26.7% | 391,447 | -0.1% | 0.14% | +41.7% |
| Q4 2021 | $23,575,000 | +7.4% | 391,805 | 0.0% | 0.10% | -1.0% |
| Q3 2021 | $21,941,000 | -10.8% | 391,805 | -3.4% | 0.10% | -9.3% |
| Q2 2021 | $24,603,000 | -13.4% | 405,456 | 0.0% | 0.11% | -19.5% |
| Q1 2021 | $28,418,000 | +17.0% | 405,456 | -0.1% | 0.13% | +12.7% |
| Q4 2020 | $24,290,000 | -0.4% | 405,916 | +0.1% | 0.12% | -8.5% |
| Q3 2020 | $24,391,000 | +9.7% | 405,706 | -4.3% | 0.13% | +1.6% |
| Q2 2020 | $22,240,000 | +56.5% | 423,870 | 0.0% | 0.13% | +28.3% |
| Q1 2020 | $14,212,000 | -26.3% | 423,870 | -0.4% | 0.10% | -9.2% |
| Q4 2019 | $19,282,000 | +19.0% | 425,660 | 0.0% | 0.11% | +10.1% |
| Q3 2019 | $16,205,000 | -12.5% | 425,660 | 0.0% | 0.10% | -13.2% |
| Q2 2019 | $18,512,000 | +27.9% | 425,660 | +12.0% | 0.11% | +23.9% |
| Q1 2019 | $14,471,000 | -11.5% | 380,213 | 0.0% | 0.09% | -22.0% |
| Q4 2018 | $16,357,000 | -12.5% | 380,213 | 0.0% | 0.12% | +4.4% |
| Q3 2018 | $18,687,000 | +86.1% | 380,213 | +21.4% | 0.11% | +73.8% |
| Q2 2018 | $10,041,000 | +16.4% | 313,288 | +13.1% | 0.06% | +14.0% |
| Q1 2018 | $8,625,000 | -32.9% | 276,888 | -1.7% | 0.06% | -30.5% |
| Q4 2017 | $12,854,000 | +36.3% | 281,588 | +12.1% | 0.08% | +20.6% |
| Q3 2017 | $9,428,000 | -21.3% | 251,088 | 0.0% | 0.07% | -22.7% |
| Q2 2017 | $11,977,000 | +4.6% | 251,088 | 0.0% | 0.09% | +1.1% |
| Q1 2017 | $11,450,000 | +58.6% | 251,088 | +12.4% | 0.09% | +50.0% |
| Q4 2016 | $7,218,000 | -5.6% | 223,453 | 0.0% | 0.06% | -6.5% |
| Q3 2016 | $7,647,000 | +151.4% | 223,453 | +147.7% | 0.06% | +148.0% |
| Q2 2016 | $3,042,000 | +627.8% | 90,199 | +1041.9% | 0.02% | +733.3% |
| Q1 2016 | $418,000 | -22.6% | 7,899 | +12.3% | 0.00% | -40.0% |
| Q4 2015 | $540,000 | +86.9% | 7,035 | 0.0% | 0.01% | +66.7% |
| Q3 2015 | $289,000 | -42.0% | 7,035 | 0.0% | 0.00% | -25.0% |
| Q2 2015 | $498,000 | -20.3% | 7,035 | 0.0% | 0.00% | -20.0% |
| Q1 2015 | $625,000 | – | 7,035 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |